Pfizer Chairman & CEO Albert Bourla Acquires Phantom Stock via Deferred Compensation Plan
PFIZER INC
Subscribe to track PFE
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📋 Form 4 Filing: Pfizer Inc ($PFE) Insider: Albert Bourla (Chairman & CEO) Transaction: Acquired 20 Phantom Stock Units SSP at $29.44 ($588.80) Post-Transaction Holdings: 783,997 units Significance: Low (Routine supplemental savings plan accrual)
Comprehensive Analysis
Insider Filing Analysis: Pfizer Inc ($PFE)
Overview
On October 16, 2026, a Form 4 was filed on behalf of Albert Bourla, Chairman & Chief Executive Officer of Pfizer Inc ($PFE). The transaction reflects an acquisition of derivative securities on October 15, 2026.
Transaction Details
- Security: Phantom Stock Units SSP (settled in cash upon separation from service)
- Transaction Code:
A(Acquisition) - Shares/Units: 20
- Price per Unit: $29.44
- Total Value: $588.80
- Post-Transaction Beneficial Ownership: 783,997 phantom units (held directly)
Context and Significance
- Plan Details: The phantom stock units were acquired under Pfizer's Nonfunded Deferred Compensation and Supplemental Savings Plan.
- Significance Level: Low.
- This transaction represents a routine, automatic deferral or company contribution into a non-qualified deferred compensation plan rather than a discretionary open-market purchase or sale. It does not provide actionable directional sentiment for $PFE shares.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.